Mr. Gino S. Cordisco is a pharmacist who is specialized in Psychiatric in Aliquippa, Pennsylvania. Patients can reach him at 2003 Sheffield Rd, Aliquippa or contact him on 724-816-2512. Active license number of Mr. Gino S. Cordisco is RP040055L for Psychiatric in Pennsylvania. Mr. Gino S. Cordisco is a licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Complete Profile:
Mr. Gino S. Cordisco speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Mr. Gino S. Cordisco are as mentioned below.
NPI Number:
1225025539
NPI Enumeration Date:
02 Oct, 2005
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Mr. Gino S. Cordisco are as mentioned below.
Specialization
License Number
State
Status
Psychiatric
RP040055L
Pennsylvania
Primary
Pharmacist
RP040055L
Pennsylvania
Secondary
Pharmacotherapy
RP040055L
Pennsylvania
Secondary
Psychiatric
RP040055L
Pennsylvania
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
6905 Crider Rd, Mars, Pennsylvania
Zip:
16046-2355
Phone Number:
724-816-2512
Fax Number:
724-776-7237
Patients can reach Mr. Gino S. Cordisco at 2003 Sheffield Rd, Aliquippa, Pennsylvania or can call on phone at 724-816-2512.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.